{"id": "article-17990_0", "title": "Atypical Fibroxanthoma -- Continuing Education Activity", "content": "Atypical fibroxanthoma is a rare, low-grade superficial sarcoma frequently presenting as a red nodule or plaque. It is a superficial variant of undifferentiated pleomorphic sarcoma (formerly malignant fibrous histiocytoma). Although atypical fibroxanthoma has similar histologic features to undifferentiated pleomorphic sarcoma, it behaves less aggressively. This activity reviews the pathophysiology, presentation, and cause of atypical fibroxanthoma and highlights the role of the interprofessional team in its management.", "contents": "Atypical Fibroxanthoma -- Continuing Education Activity. Atypical fibroxanthoma is a rare, low-grade superficial sarcoma frequently presenting as a red nodule or plaque. It is a superficial variant of undifferentiated pleomorphic sarcoma (formerly malignant fibrous histiocytoma). Although atypical fibroxanthoma has similar histologic features to undifferentiated pleomorphic sarcoma, it behaves less aggressively. This activity reviews the pathophysiology, presentation, and cause of atypical fibroxanthoma and highlights the role of the interprofessional team in its management."}
{"id": "article-17990_1", "title": "Atypical Fibroxanthoma -- Continuing Education Activity", "content": "Objectives: Identify the etiology of atypical fibroxanthoma. Assess\u00a0the presentation of atypical fibroxanthoma. Determine\u00a0the management options available for atypical fibroxanthoma. Communicate\u00a0the interprofessional team strategies for improving care coordination regarding managing patients with atypical fibroxanthoma. Access free multiple choice questions on this topic.", "contents": "Atypical Fibroxanthoma -- Continuing Education Activity. Objectives: Identify the etiology of atypical fibroxanthoma. Assess\u00a0the presentation of atypical fibroxanthoma. Determine\u00a0the management options available for atypical fibroxanthoma. Communicate\u00a0the interprofessional team strategies for improving care coordination regarding managing patients with atypical fibroxanthoma. Access free multiple choice questions on this topic."}
{"id": "article-17990_2", "title": "Atypical Fibroxanthoma -- Introduction", "content": "Atypical fibroxanthoma is a rare, low-grade superficial sarcoma frequently presenting as a red nodule or plaque. It is a superficial variant of undifferentiated pleomorphic sarcoma (formerly malignant fibrous histiocytoma). Although atypical fibroxanthoma\u00a0has similar histologic features to undifferentiated pleomorphic sarcoma, it behaves less aggressively. [1] [2] [3] [4]", "contents": "Atypical Fibroxanthoma -- Introduction. Atypical fibroxanthoma is a rare, low-grade superficial sarcoma frequently presenting as a red nodule or plaque. It is a superficial variant of undifferentiated pleomorphic sarcoma (formerly malignant fibrous histiocytoma). Although atypical fibroxanthoma\u00a0has similar histologic features to undifferentiated pleomorphic sarcoma, it behaves less aggressively. [1] [2] [3] [4]"}
{"id": "article-17990_3", "title": "Atypical Fibroxanthoma -- Etiology", "content": "The etiology of atypical fibroxanthomas is poorly understood. Researchers believe it arises from myofibroblasts or fibroblast-like cells. Ultraviolet light appears to play a significant role since most lesions appear on the sun-exposed head and neck of White race patients. Genetic factors also contribute to the development of atypical\u00a0fibroxanthoma since it shares genetic alterations with undifferentiated pleomorphic sarcomas, including chromosome 9p and 13q deletions. However, undifferentiated pleomorphic sarcoma\u00a0has a statistically significant larger amount of genomic alterations and a more aggressive clinical course. Other possible risk factors for atypical\u00a0fibroxanthoma\u00a0include trauma to the skin, radiation therapy, and immunosuppression (eg, diabetes, HIV, organ transplant). [5] [6] [7] [8] [8]", "contents": "Atypical Fibroxanthoma -- Etiology. The etiology of atypical fibroxanthomas is poorly understood. Researchers believe it arises from myofibroblasts or fibroblast-like cells. Ultraviolet light appears to play a significant role since most lesions appear on the sun-exposed head and neck of White race patients. Genetic factors also contribute to the development of atypical\u00a0fibroxanthoma since it shares genetic alterations with undifferentiated pleomorphic sarcomas, including chromosome 9p and 13q deletions. However, undifferentiated pleomorphic sarcoma\u00a0has a statistically significant larger amount of genomic alterations and a more aggressive clinical course. Other possible risk factors for atypical\u00a0fibroxanthoma\u00a0include trauma to the skin, radiation therapy, and immunosuppression (eg, diabetes, HIV, organ transplant). [5] [6] [7] [8] [8]"}
{"id": "article-17990_4", "title": "Atypical Fibroxanthoma -- Epidemiology", "content": "Atypical fibroxanthomas are most commonly seen on the head and neck of\u00a0older\u00a0white patients. Other reported sites of atypical\u00a0fibroxanthoma\u00a0include the trunk, shoulders, upper extremities, and dorsum of the hands. Trunk and limb lesions appear more commonly in younger patients (mean age 39) than head and neck lesions in the elderly (mean age 69). A review of 171 cases in Western Australia found a patient age range of 41 to 97 years old (median age 74), with 76% of the tumors occurring in men. Atypical\u00a0fibroxanthoma has also been reported in patients as young as 13\u00a0with predisposing disorders such as Li-Fraumeni syndrome and xeroderma pigmentosum. The incidence increases in immunosuppressed populations, with an estimated 78 per 100,000 transplant patients.", "contents": "Atypical Fibroxanthoma -- Epidemiology. Atypical fibroxanthomas are most commonly seen on the head and neck of\u00a0older\u00a0white patients. Other reported sites of atypical\u00a0fibroxanthoma\u00a0include the trunk, shoulders, upper extremities, and dorsum of the hands. Trunk and limb lesions appear more commonly in younger patients (mean age 39) than head and neck lesions in the elderly (mean age 69). A review of 171 cases in Western Australia found a patient age range of 41 to 97 years old (median age 74), with 76% of the tumors occurring in men. Atypical\u00a0fibroxanthoma has also been reported in patients as young as 13\u00a0with predisposing disorders such as Li-Fraumeni syndrome and xeroderma pigmentosum. The incidence increases in immunosuppressed populations, with an estimated 78 per 100,000 transplant patients."}
{"id": "article-17990_5", "title": "Atypical Fibroxanthoma -- Pathophysiology", "content": "The pathophysiology of atypical fibroxanthomas is poorly characterized. Ultra-violet (UV) light has implications for its pathogenesis due to atypical\u00a0fibroxanthoma\u00a0predilection for sun-exposed areas of the body and the presence of atypical\u00a0fibroxanthoma in xeroderma pigmentosum patients who exhibit defective repair of UV-induced cyclobutane pyrimidine dimers. Research has documented these UV-induced pyrimidine dimers in atypical\u00a0fibroxanthoma\u00a0lesions and mutations in the tumor suppressor gene p53. Various rare genetic disorders have correlations with p53-induced atypical fibroxanthomas, including Li-Fraumeni syndrome (with germline p53 mutations) and xeroderma pigmentosum. One study showed that mutations of H-Ras and K-Ras genes were present in malignant fibrous histiocytoma\u00a0but not in atypical\u00a0fibroxanthoma\u00a0lesions; this research may prove helpful in establishing the diagnosis of atypical\u00a0fibroxanthoma.", "contents": "Atypical Fibroxanthoma -- Pathophysiology. The pathophysiology of atypical fibroxanthomas is poorly characterized. Ultra-violet (UV) light has implications for its pathogenesis due to atypical\u00a0fibroxanthoma\u00a0predilection for sun-exposed areas of the body and the presence of atypical\u00a0fibroxanthoma in xeroderma pigmentosum patients who exhibit defective repair of UV-induced cyclobutane pyrimidine dimers. Research has documented these UV-induced pyrimidine dimers in atypical\u00a0fibroxanthoma\u00a0lesions and mutations in the tumor suppressor gene p53. Various rare genetic disorders have correlations with p53-induced atypical fibroxanthomas, including Li-Fraumeni syndrome (with germline p53 mutations) and xeroderma pigmentosum. One study showed that mutations of H-Ras and K-Ras genes were present in malignant fibrous histiocytoma\u00a0but not in atypical\u00a0fibroxanthoma\u00a0lesions; this research may prove helpful in establishing the diagnosis of atypical\u00a0fibroxanthoma."}
{"id": "article-17990_6", "title": "Atypical Fibroxanthoma -- Histopathology", "content": "Hematoxylin and eosin stains of atypical\u00a0fibroxanthoma\u00a0lesions show a dermally-based tumor with pleomorphism, atypical mitotic figures, and a spindly architecture. Atypical\u00a0fibroxanthoma\u00a0lesions occasionally extend to the subcutaneous tissue. Note that atypical\u00a0fibroxanthoma\u00a0is a dermal-based process, while spindle cell squamous cell carcinoma variants (on the differential diagnosis) connect with the epidermis and show signs of keratinization. Multinucleated giant cells and solar elastosis are often present in atypical\u00a0fibroxanthoma\u00a0biopsy specimens, while a mixed inflammatory infiltrate may be found at the edge of the tumor. Immunohistochemistry is required to rule out other neoplasms, including spindloid\u00a0squamous cell carcinoma, melanoma, and undifferentiated pleomorphic sarcoma.", "contents": "Atypical Fibroxanthoma -- Histopathology. Hematoxylin and eosin stains of atypical\u00a0fibroxanthoma\u00a0lesions show a dermally-based tumor with pleomorphism, atypical mitotic figures, and a spindly architecture. Atypical\u00a0fibroxanthoma\u00a0lesions occasionally extend to the subcutaneous tissue. Note that atypical\u00a0fibroxanthoma\u00a0is a dermal-based process, while spindle cell squamous cell carcinoma variants (on the differential diagnosis) connect with the epidermis and show signs of keratinization. Multinucleated giant cells and solar elastosis are often present in atypical\u00a0fibroxanthoma\u00a0biopsy specimens, while a mixed inflammatory infiltrate may be found at the edge of the tumor. Immunohistochemistry is required to rule out other neoplasms, including spindloid\u00a0squamous cell carcinoma, melanoma, and undifferentiated pleomorphic sarcoma."}
{"id": "article-17990_7", "title": "Atypical Fibroxanthoma -- Histopathology", "content": "Since atypical\u00a0fibroxanthoma\u00a0stains are positive for several non-specific stains, including CD10, p53, S100A6, vimentin, and procollagen-1, it is considered a diagnosis of exclusion histologically. Of note, atypical\u00a0fibroxanthoma\u00a0stains negative for HMB-45, p40 (often positive in squamous cell carcinoma), desmin, pan-cytokeratin stains, CD31, and has sparse staining for S100, which may help differentiate it from melanoma. Since poorly differentiated sarcomatoid carcinomas may lose cytokeratin expression, various cytokeratin stains should be used. Severe variants of atypical\u00a0fibroxanthoma\u00a0have been described based on various histologic findings, including pigmented atypical\u00a0fibroxanthoma\u00a0due to hemosiderin deposit and not actual melanin pigment, granular cell atypical\u00a0fibroxanthoma, sclerotic atypical\u00a0fibroxanthoma, spindle cell nonpleomorphic atypical\u00a0fibroxanthoma, osteoid atypical\u00a0fibroxanthoma, chondroid atypical\u00a0fibroxanthoma, myxoid atypical\u00a0fibroxanthoma, keloidal atypical\u00a0fibroxanthoma, osteoclast-like giant-cell rich atypical\u00a0fibroxanthoma, and clear cell atypical\u00a0fibroxanthoma.", "contents": "Atypical Fibroxanthoma -- Histopathology. Since atypical\u00a0fibroxanthoma\u00a0stains are positive for several non-specific stains, including CD10, p53, S100A6, vimentin, and procollagen-1, it is considered a diagnosis of exclusion histologically. Of note, atypical\u00a0fibroxanthoma\u00a0stains negative for HMB-45, p40 (often positive in squamous cell carcinoma), desmin, pan-cytokeratin stains, CD31, and has sparse staining for S100, which may help differentiate it from melanoma. Since poorly differentiated sarcomatoid carcinomas may lose cytokeratin expression, various cytokeratin stains should be used. Severe variants of atypical\u00a0fibroxanthoma\u00a0have been described based on various histologic findings, including pigmented atypical\u00a0fibroxanthoma\u00a0due to hemosiderin deposit and not actual melanin pigment, granular cell atypical\u00a0fibroxanthoma, sclerotic atypical\u00a0fibroxanthoma, spindle cell nonpleomorphic atypical\u00a0fibroxanthoma, osteoid atypical\u00a0fibroxanthoma, chondroid atypical\u00a0fibroxanthoma, myxoid atypical\u00a0fibroxanthoma, keloidal atypical\u00a0fibroxanthoma, osteoclast-like giant-cell rich atypical\u00a0fibroxanthoma, and clear cell atypical\u00a0fibroxanthoma."}
{"id": "article-17990_8", "title": "Atypical Fibroxanthoma -- Toxicokinetics", "content": "While there is no direct association to date, researchers\u00a0hypothesize\u00a0that arsenic exposure may predispose patients to atypical\u00a0fibroxanthoma.", "contents": "Atypical Fibroxanthoma -- Toxicokinetics. While there is no direct association to date, researchers\u00a0hypothesize\u00a0that arsenic exposure may predispose patients to atypical\u00a0fibroxanthoma."}
{"id": "article-17990_9", "title": "Atypical Fibroxanthoma -- History and Physical", "content": "Atypical fibroxanthomas present as well-circumscribed red or pink nodules or plaque that may have ulceration, crust, or scale. Atypical\u00a0fibroxanthoma\u00a0lesions are typically small in size, with a median diameter of 1 cm, with less than 5% of the\u00a0lesions being greater than 2 cm in diameter. They often develop rapidly but lack symptoms such as pain or pruritus. More than 90% of atypical\u00a0fibroxanthoma\u00a0tumors occur on the head and neck, while the remaining cases typically present on the extremities and trunk. Dermoscopy of lesions reveals polymorphic vessels (linear, dotted, hairpin, arborescent, and/or highly tortuous vessels) radiating to the center of the lesion with intervening white areas. The differential diagnosis includes basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, amelanotic melanoma, leiomyosarcoma, atypical (pseudosarcomatous) dermatofibroma, pleomorphic dermal sarcomas, and metastasis from internal malignancies. Compared to atypical\u00a0fibroxanthoma,\u00a0pleomorphic dermal sarcomas\u00a0are\u00a0often\u00a0clinically\u00a0larger and are more likely to recur locally and metastasize.", "contents": "Atypical Fibroxanthoma -- History and Physical. Atypical fibroxanthomas present as well-circumscribed red or pink nodules or plaque that may have ulceration, crust, or scale. Atypical\u00a0fibroxanthoma\u00a0lesions are typically small in size, with a median diameter of 1 cm, with less than 5% of the\u00a0lesions being greater than 2 cm in diameter. They often develop rapidly but lack symptoms such as pain or pruritus. More than 90% of atypical\u00a0fibroxanthoma\u00a0tumors occur on the head and neck, while the remaining cases typically present on the extremities and trunk. Dermoscopy of lesions reveals polymorphic vessels (linear, dotted, hairpin, arborescent, and/or highly tortuous vessels) radiating to the center of the lesion with intervening white areas. The differential diagnosis includes basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, amelanotic melanoma, leiomyosarcoma, atypical (pseudosarcomatous) dermatofibroma, pleomorphic dermal sarcomas, and metastasis from internal malignancies. Compared to atypical\u00a0fibroxanthoma,\u00a0pleomorphic dermal sarcomas\u00a0are\u00a0often\u00a0clinically\u00a0larger and are more likely to recur locally and metastasize."}
{"id": "article-17990_10", "title": "Atypical Fibroxanthoma -- Evaluation", "content": "A skin biopsy is the diagnostic gold standard for atypical\u00a0fibroxanthoma, a rare condition that clinically mimics basal and squamous cell carcinomas, Merkel cell carcinomas, and amelanotic melanomas. Immunohistochemistry is a common test used to make the diagnosis (see \"histopathology\" above). When atypical\u00a0fibroxanthoma\u00a0lesions have metastasized or are poorly accessible (eg, subungual lesions), magnetic resonance imaging (MRI) may be helpful. MRI shows intermediate T1 and T2-weighted signal intensity compared to the high signal intensity of squamous cell carcinoma and melanoma.", "contents": "Atypical Fibroxanthoma -- Evaluation. A skin biopsy is the diagnostic gold standard for atypical\u00a0fibroxanthoma, a rare condition that clinically mimics basal and squamous cell carcinomas, Merkel cell carcinomas, and amelanotic melanomas. Immunohistochemistry is a common test used to make the diagnosis (see \"histopathology\" above). When atypical\u00a0fibroxanthoma\u00a0lesions have metastasized or are poorly accessible (eg, subungual lesions), magnetic resonance imaging (MRI) may be helpful. MRI shows intermediate T1 and T2-weighted signal intensity compared to the high signal intensity of squamous cell carcinoma and melanoma."}
{"id": "article-17990_11", "title": "Atypical Fibroxanthoma -- Treatment / Management", "content": "Fortunately, atypical\u00a0fibroxanthoma\u00a0rarely metastasizes and recurs in only 6% to 10% of cases. Risk factors for metastases include immunocompromised patients, tumor depth, vascular or perineural invasion, and the presence of tumor necrosis. The most commonly reported locations for metastases include the parotid gland, lymph nodes, and subcutaneous tissue. Metastases, when present, are typically evident 12 to 24 months after the initial diagnosis of atypical\u00a0fibroxanthoma. The treatment of choice for atypical\u00a0fibroxanthoma\u00a0is surgical excision.\u00a0Previously, this utilized 1 cm margins, however Mohs micrographic surgery and regular follow-up have become the standard of care, with recurrence rates reported at 0.0% to 6.9%. In patients who are poor surgical candidates, electronic brachytherapy\u00a0has successfully treated atypical\u00a0fibroxanthoma\u00a0and is even more effective if there is tumor debulking before therapy. Another reported treatment modality is electrodesiccation and curettage, which may be appropriate for slow-growing lesions less than 1 cm\u00a0in diameter.", "contents": "Atypical Fibroxanthoma -- Treatment / Management. Fortunately, atypical\u00a0fibroxanthoma\u00a0rarely metastasizes and recurs in only 6% to 10% of cases. Risk factors for metastases include immunocompromised patients, tumor depth, vascular or perineural invasion, and the presence of tumor necrosis. The most commonly reported locations for metastases include the parotid gland, lymph nodes, and subcutaneous tissue. Metastases, when present, are typically evident 12 to 24 months after the initial diagnosis of atypical\u00a0fibroxanthoma. The treatment of choice for atypical\u00a0fibroxanthoma\u00a0is surgical excision.\u00a0Previously, this utilized 1 cm margins, however Mohs micrographic surgery and regular follow-up have become the standard of care, with recurrence rates reported at 0.0% to 6.9%. In patients who are poor surgical candidates, electronic brachytherapy\u00a0has successfully treated atypical\u00a0fibroxanthoma\u00a0and is even more effective if there is tumor debulking before therapy. Another reported treatment modality is electrodesiccation and curettage, which may be appropriate for slow-growing lesions less than 1 cm\u00a0in diameter."}
{"id": "article-17990_12", "title": "Atypical Fibroxanthoma -- Differential Diagnosis", "content": "The differential diagnoses for atypical fibroxanthoma  include the following: Amelanotic melanoma Atypical fibroxanthoma Basal cell carcinoma Dermatofibroma with monster cell Leiomyosarcoma undifferentiated pleomorphic sarcoma Melanoma Merkel cell carcinoma Neurothekeoma Pleomorphic dermal", "contents": "Atypical Fibroxanthoma -- Differential Diagnosis. The differential diagnoses for atypical fibroxanthoma  include the following: Amelanotic melanoma Atypical fibroxanthoma Basal cell carcinoma Dermatofibroma with monster cell Leiomyosarcoma undifferentiated pleomorphic sarcoma Melanoma Merkel cell carcinoma Neurothekeoma Pleomorphic dermal"}
{"id": "article-17990_13", "title": "Atypical Fibroxanthoma -- Prognosis", "content": "Atypical fibroxanthoma\u00a0rates\u00a0a low-grade sarcoma, usually occurring on sun-exposed areas of the head and neck in elderly patients. The prognosis is generally excellent when treated with adequate primary tumor excision. Recurrence of the tumor occurs in approximately 5% of cases. [9] [7] [10]", "contents": "Atypical Fibroxanthoma -- Prognosis. Atypical fibroxanthoma\u00a0rates\u00a0a low-grade sarcoma, usually occurring on sun-exposed areas of the head and neck in elderly patients. The prognosis is generally excellent when treated with adequate primary tumor excision. Recurrence of the tumor occurs in approximately 5% of cases. [9] [7] [10]"}
{"id": "article-17990_14", "title": "Atypical Fibroxanthoma -- Complications", "content": "When promptly addressed and treated through adequate excision, atypical fibroxanthoma seldom causes complications. It can exhibit significant sclerosis in some instances. [11] There have also been some cases of metastatic involvement, although rare. [12]", "contents": "Atypical Fibroxanthoma -- Complications. When promptly addressed and treated through adequate excision, atypical fibroxanthoma seldom causes complications. It can exhibit significant sclerosis in some instances. [11] There have also been some cases of metastatic involvement, although rare. [12]"}
{"id": "article-17990_15", "title": "Atypical Fibroxanthoma -- Pearls and Other Issues", "content": "Prevention of atypical fibroxanthoma is centered around UV protection and yearly full-body skin exams for early detection.", "contents": "Atypical Fibroxanthoma -- Pearls and Other Issues. Prevention of atypical fibroxanthoma is centered around UV protection and yearly full-body skin exams for early detection."}
{"id": "article-17990_16", "title": "Atypical Fibroxanthoma -- Enhancing Healthcare Team Outcomes", "content": "Healthcare\u00a0clinicians may frequently encounter skin growth in patients. Because the differential of dermal growths is large, these patients require a referral to a dermatologist or plastic surgeon for a definitive diagnosis. Atypical fibroxanthoma is\u00a01 such growth that often presents in elderly persons of the White race. Risk factors for metastases include immunocompromised patients, tumor depth, vascular or perineural invasion, and the presence of tumor necrosis. The most commonly reported locations for metastases include the parotid gland, lymph nodes, and subcutaneous tissue. The treatment of choice for atypical\u00a0fibroxanthoma\u00a0is surgical excision. The key is to educate the patient on avoiding sun exposure and getting regular physical exams for early detection. Recurrence can occur, but metastatic spread is rare. [12] [13]", "contents": "Atypical Fibroxanthoma -- Enhancing Healthcare Team Outcomes. Healthcare\u00a0clinicians may frequently encounter skin growth in patients. Because the differential of dermal growths is large, these patients require a referral to a dermatologist or plastic surgeon for a definitive diagnosis. Atypical fibroxanthoma is\u00a01 such growth that often presents in elderly persons of the White race. Risk factors for metastases include immunocompromised patients, tumor depth, vascular or perineural invasion, and the presence of tumor necrosis. The most commonly reported locations for metastases include the parotid gland, lymph nodes, and subcutaneous tissue. The treatment of choice for atypical\u00a0fibroxanthoma\u00a0is surgical excision. The key is to educate the patient on avoiding sun exposure and getting regular physical exams for early detection. Recurrence can occur, but metastatic spread is rare. [12] [13]"}
{"id": "article-17990_17", "title": "Atypical Fibroxanthoma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Atypical Fibroxanthoma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}